Report Categories
View AllRecent Articles
View All
Is Keros Therapeutics Kros Stock Breaking Out Price At 11.60 Down 7.13 20260410
Daily Market Overview Nasdaq Leads Mild Gains As Dow And S P 500 Also Close Higher 20260406 1
What Is The Price Target For Xcf Global Safx Stock Price At 0.58 Down 16.55 20260409
Is Invesco Vbf Stock Consolidating Price At 15.00 Up 0.54 20260406
CoastalSouth COSO Stock Why Intellectual Property Market Focus 20260418
TELA Bio TELA Stock Bonus Issue Technical Strength 20260415
MFA MFAN Stock Is It Safe Smart Money Outflows 20260415
NNBR NN Inc stock gains nearly 14 percent even as it misses Q4 2025 earnings estimates
X Strengthens Content Moderation Commitments in UK Following Ofcom Pressure
Trumps China Visit Musk Cook and Nvidias Huang Join HighStakes Trade Talks
Maldives Rescue Diver Dies in Search for Italian Tourists Potential Implications for Tourism Safety
UK Economy Defies War Concerns Surprise 03 Growth in March
CN Energy CNEY Stalls at 076 Consolidation Phase 20260514
Fifth FITB Q1 2026 Earnings Beat Revenue NA EPS 084
AmpereHour and IndiGrid Commission 180MW Battery Energy Storage System in Gujarat
Why Blend BLND Just Dropped 538 What to Watch 20260519
YSX Tech YSXT Q2 2025 Results Meet Expectations Revenue 7145273600
Applied Mat AMAT Surges 490 Nearing 44819 Resistance 20260520
SWKHL Q3 2025 Earnings Strong EPS Beat Drives Modest Gains in Senior Notes
Eagle ECCV Q1 2026 Earnings Soft Quarter Raises Questions
PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances
CIG Q1 2026 Earnings EPS Beat Fails to Ignite Stock as Revenue Details Remain Absent
DOYU Q4 2025 Earnings Earnings Beat Estimates by Wide Margin Revenue Details Pending
Compass COMP Q1 2026 Earnings EPS Beats Estimates by Wide Margin Despite Revenue Uncertainty
Runway Growth Finance Corp Q1 2026 Earnings EPS Misses Estimates Amid Stable Portfolio Performance
Climb Bio Inc CLYM Advances 3 as Biotech Momentum Builds
FiEE Inc FIEE Edges Lower as Stock Tests Key Support Around 580
ECARX Holdings ECX Faces Continued Pressure Near 100 Level
Beam Therapeutics BEAM Rises 35 as Gene Editing Sector Gains Traction